Clinical Trial Details
| Trial ID: | L4528 |
| Source ID: | NCT00605449 |
| Associated Drug: | Gsk376501 |
| Title: | A Drug Interaction Study Between Simvastatin and GSK376501 |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: GSK376501 |
| Outcome Measures: | Primary: drug plasma levels of GSK376501:, Day 7 Periods 1, 2 & 3 | Secondary: drug plasma levels of GSK376501:, Day 7 all periods|adverse events, vital signs, con meds:, each visit, all periods|labs:, Days 4 & 8 all periods|ECGs:, Days 1-7 all periods|Simvastatin acid Day 7 tmax and t1/2.|Simvastatin Day 7 AUC(0-24), Cmax, tmax and t1/2.|GSK376501 Day 7 AUC(0-24), Cmax, tmax and t1/2. |
| Sponsor/Collaborators: | Sponsor: GlaxoSmithKline |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 39 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2008-01 |
| Completion Date: | 2008-03 |
| Results First Posted: | |
| Last Update Posted: | 2010-10-19 |
| Locations: | GSK Investigational Site, Austin, Texas, 78744, United States |
| URL: | https://clinicaltrials.gov/show/NCT00605449 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|